Researcher loses second bid to quash Diabetes expressions of concern

Mario Saad, via unicamp.br
Mario Saad, via unicamp.br

It hasn’t been a good week for scientists going to court to silence criticism of their work.

Yesterday, PubPeer won a near-complete victory in a case seeking the identities of their commenters. And also yesterday, a Massachusetts judge struck down — for the second time — a request by Mario Saad to remove expressions of concern about four of his papers in Diabetes.

In his ruling, Judge Timothy Hillman wrote: Continue reading Researcher loses second bid to quash Diabetes expressions of concern

Psychology retractions have quadrupled since 1989: study

stapel
Diederik Stapel

Marc Hauser. Dirk Smeesters. Diederik Stapel.

Psychology has been home to some of the most infamous cases of fraud in recent years, and while it’s just a few bad apples who are spoiling the bunch, the field itself has seen an overall increase in retractions, according to a new paper by Jürgen Margraf appearing in Psychologische Rundschau and titled “Zur Lage der Psychologie.”

That increase, Margraf found, is not entirely due to its most well-known fraudsters. Here’s the relevant figure:

Continue reading Psychology retractions have quadrupled since 1989: study

Diabetes researcher won’t give up court fight to quash expressions of concern

Mario Saad, via unicamp.br
Mario Saad, via unicamp.br

Apparently, you can’t keep Mario Saad down.

The researcher, who had 12 figures in a paper corrected this week, was dealt a setback last week when a judge denied his motion to remove expressions of concern on four of his papers in the journal Diabetes, saying that would have amounted to prior restraint — essentially, censorship (a no-no, thanks to the First Amendment).

Saad and his attorneys, however, were undeterred. They filed a motion for reconsideration just four days later, along with a brief, arguing: Continue reading Diabetes researcher won’t give up court fight to quash expressions of concern

Weekend reads: P values banned, climate skeptic fails to disclose corporate funding, editors behaving badly

booksThis week at Retraction Watch featured a change of heart by a journal, and a look at Nature’s addition of double-blind peer review. Here’s what was happening elsewhere: Continue reading Weekend reads: P values banned, climate skeptic fails to disclose corporate funding, editors behaving badly

Prominent geneticist David Latchman’s group notches second retraction

j cell scienceA team of researchers whose work is under investigation by University College London has retracted a second paper.

Three of the 11 authors of the 2005 Journal of Cell Science paper being retracted — David Latchman, Richard Knight, and Anastasis Stephanou — were authors of a Journal of Biological Chemistry paper retracted in January. Stephanou takes the blame for the “errors” which felled the Journal of Cell Science paper, about how a tumor suppressor responds to DNA damage.

Here’s the notice for “STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage:” Continue reading Prominent geneticist David Latchman’s group notches second retraction

Are retractions more frequent in stem cell research?

sci eng ethicsThere are a number of fields that seem to punch above their weight on Retraction Watch: Anesthesiology, home to the world record holder (and runner-up), and psychology, home to Diederik Stapel and others. But the red-hot field of stem cell research is another that makes frequent appearances, last year’s STAP controversy being particularly prominent.

There’s an interesting (but unfortunately paywalled) recent paper in Science and Engineering Ethics, “The Acid Test for Biological Science: STAP Cells, Trust, and Replication,” by Cheryl Lancaster, a small part of which tries to answer that question.

Lancaster applies the same methods Fang, Steen, and Casadevall used to broadly measure the causes of retractions in all life science and biomedicine to the specific field of stem cell research: Continue reading Are retractions more frequent in stem cell research?

Judge denies motion by researcher to quash Diabetes expressions of concern

Mario Saad, via unicamp.br
Mario Saad, via unicamp.br

American Diabetes Association 1, Mario Saad 0.

As reported by the National Law Journal, a federal judge in Boston has denied Saad’s requests to stop the ADA’s flagship journal, Diabetes, from publishing expressions of concern about four of Saad’s papers, and to prevent the journal from retracting the studies.

Saad filed suit against the ADA on February 5. Judge Timothy Hillman wrote in his order yesterday that approving the researcher’s motion would have violated the right to free speech: Continue reading Judge denies motion by researcher to quash Diabetes expressions of concern

Weekend reads: Why some scientists lie, the state of academic integrity in Iran, Nature goes double-blind

booksThe week at Retraction Watch featured Matlab miscoding and a look at how often a retracted paper was cited. Here’s what was happening elsewhere: Continue reading Weekend reads: Why some scientists lie, the state of academic integrity in Iran, Nature goes double-blind

Weekend reads: Tortured reviewers, why failure is good, journals without editors?

booksThis week at Retraction Watch, an explosives paper burned up, and we found that we’re cited in a $8 million lawsuit. Here’s what’s happening elsewhere: Continue reading Weekend reads: Tortured reviewers, why failure is good, journals without editors?